This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Helen Whitby, Ph.D.
Bioseparations Specialist at Phenomenex


My name is Dr Helen Whitby and I have been with Phenomenex since 2007. I am a senior technical specialist working in our technical department and specialize in Bioseparations and bulk and preparative chromatography. Before joining the technical department in 2017 I worked for 10 years in the UK sales team as the bulk and prep specialist and HPLC product manager for the UK sales team.

I have a PhD from the University of Manchester working on analogues of Shikimic acid to treat malaria and prior to joining Phenomenex worked for 12 months in Chicago as a Post-doctoral researcher at the University of Illinois in Chicago on electron-deficient divalent reactive intermediates specifically nitrenium ions for the development of antiviral agents to treat Ebola.

Agenda Sessions

  • Synthetic Oligonucleotides Aren’t Perfect: bioZen Oligo, Paired with HRMS, Elucidates What You’re Missing